N-NOSE is a cancer screening test takes advantage of the keen olfactory sensors of nematodes.
The test will be available to the public in Japan in January 2020.
What is N-NOSE?
Merit of taking a cancer screening test
The world's first biological diagnostic technology.
At Hirotsu Bio Science, we contribute to the development of revolutionary disease diagnostic technologies to lessen your concerns over health.
Message from CEO
List of Officers
This paper is the first report on the possibility that our cancer test N-NOSE could be applied to non-human animals. This time, we used urine fr . . .
N-NOSE was in the Mainichi Shinbun on October 13.
CEO Hirotsu's book was introduced in the Asahi Shimbun's website for book information.
Good Life with Books（Japanese）
CEO Hirotsu's book was introduced in the Shukan Bunshun in October 17 issue.
On October 1, Kurume City, Ogori City, and HIROTSU BIO SCIENCE held a joint press conference. The two cities participates in the trial test of . . .
Nenpo News is published by Kenporen (National Federation of Health Insurance Societies) consists of 1,389 health insurance societies. N-NOSE was . . .
CEO Hirotsu will appear on STS forum (Science and Technology in Society forum) held in Kyoto during October 6-8. Hirotsu will be in the session . . .
On August 20, Hirotsu's book on N-NOSE, nematode studies, and his biography has been released. PRESS RELEASEClick here for more details → Kobunsha
HIROTSU BIO SCIENCE has become a supporting member for RunLink, a project started by JAAF, Japan Association of Athletics Federations aiming at . . .
CEO Hirotsu will take the platform at the 7th "Society for the Study of Cancer and Metabolism" in Miyagi on August 1 (Thursday).
Click here . . .
The world’s first cancer screening using biological diagnostic technology